Towards a dynamic customised therapy for ocular surface dysfunctions

British Journal of Ophthalmology

Volumn 97, Issue 8, 2013, Pages 955-960

  Aragona, Pasquale ^a   Rolando, Maurizio ^b,c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Is Pre   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE; TRIACYLGLYCEROL LIPASE;

CHRONIC DISEASE; CLINICAL EVALUATION; DISEASE CLASSIFICATION; DRY EYE; EYE EXAMINATION; HUMAN; LACRIMAL FLUID; MEIBOMIAN GLAND DYSFUNCTION; OCULAR SURFACE DISEASE; PATHOGENICITY; PRIORITY JOURNAL; PUNCTATE KERATITIS; REVIEW; TEAR FILM;

CONJUNCTIVA; CORNEA; OCULAR SURFACE; TEARS; TREATMENT MEDICAL;

CONJUNCTIVAL DISEASES; CORNEAL DISEASES; CRANIAL NERVE DISEASES; EYELID DISEASES; FACIAL NERVE DISEASES; HUMANS; LACRIMAL APPARATUS DISEASES; OPHTHALMIC NERVE;

EID: 84880035564     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-302568     Document Type: Review

References (40)

1. Rolando M, Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol 2001;45:S203-10.
2. No authors listed. The definition and classification of dry eye disease: report of the Definition and Classi fication Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:75-92.
3. Tseng SC, Tsubota K. Important concepts for treating ocular surface and tear disorders. Am J Ophthalmol 1997;124:825-35. (Pubitemid 27523160)
4. Rolando M, Calabria G. "Superficie Oculare e Sostituti Lacrimali" 1994, pag 1-4, SAGEP ed. Genoa, Italy. ISBN: 88-7058-540-9.
5. Jordan A, Baum J. Basic tear flow. Does it exist? Ophthalmology 1980;87:920-30. (Pubitemid 11212992)
6. Buck RC. Measurement of centripetal migration of normal corneal epithelial cells in the mouse. Invest Ophthalmol Vis Sci 1985;26:1296-9. (Pubitemid 15237922)
7. Buck RC. Cell migration in repair of mouse corneal epithelium. Invest Ophthalmol Vis Sci 1979;18:767-84. (Pubitemid 9212706)
8. Asari A, Morita M, Sekiguchi T, et al.: Hyaluronan, CD44 and fibronectin in rabbit corneal epithelial wound healing. Jpn J Ophthalmol 1996;40:18-25. (Pubitemid 26134339)
9. Wilson SE, Liang Q, Kim WJ: Lacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial wounding. Invest Ophthalmol Vis Sci 1999;40:2185-90. (Pubitemid 29418371)
10. Holly F, Lemp MA. Formation and rupture of the tear film. Exp Eye Res 1973;15:515-25.
11. Bron AJ. Diagnosis of dry eye. Surv Ophthalmol 2001;45(2 Suppl):S221-6.
12. Goto T, Zheng X, Klyce SD, et al. A new method for tear film stability using videokeratography. Am J Ophthalmol 2003;135:607-12. (Pubitemid 36457965)
13. Rolando M, Terragna F, Giordano G, et al. Conjunctival surface damage distribution in keratoconjunctivitis sicca. An impression cytology study. Ophthalmologica 1990;200:170-6. (Pubitemid 20214089)
14. McDermott AM, Perez V, Huang AJW, et al. Pathways of corneal and ocular surface inflammation: A perspective from the Cullen Symposium. Ocul Surf 2005;3(4 Suppl):S131-8.
15. Argueso P, Baloram M, Spurr-Michaud S, et al. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren Syndrome. Invest Ophthalmol Vis Sci 2002;43:1004-11. (Pubitemid 34258267)
16. Chen Y-T, Nikulina K, Stanislav L, et al. Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren's syndrome. Am J Pathol 2010;177:1333-43.
17. Baudouin C. Un nouveau schema pour mieux comprendre les maladies de la surface oculaire. J Fr Ophtalmol 2007;3:239-46.
18. Aragona P, Rania L, Puzzolo D. The role of inflammation, inflammatory cytokines and ocular surface markers in dry eye syndrome. In: Benitez del Castillo JM, Lemp MA, eds. Ocular surface disorders. London: JP Morgan Publishing, 2012, In press.
19. Zhang X, Chen W, De Paiva CS, et al. Interferon-gamma exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways. Invest Ophthalmol Vis Sci 2011;52:6279-85.
20. Graham JE, Moore JE, Jiru X, et al. Ocular pathogen or commensal: a PCR-based study of surface bacterial flora in normal and dry eyes. Invest Ophthalmol Vis Sci 2007;48:5616-23. (Pubitemid 351260863)
21. Pflugfelder SC, Stern ME. Immunoregulation on the ocular surface. Ocul Surf 2009;7:67-77.
22. Rolando M, Refojo MF, Kenyon KR. Tear water evaporation and eye surface diseases. Ophthalmologica 1985;190:147-9. (Pubitemid 15149275)
23. Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006;25:900-7. (Pubitemid 44763848)
24. Bron AJ, Yokoi N, Gafney E, et al. Predicted phenotypes of dry eye: proposed consequences of its natural history. Ocul Surf 2009;7:78-92.
25. Lagnado R, King AJ, Donald F, et al. A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol 2004;88:464-5. (Pubitemid 38437859)
26. Birch CS, Brasch NE, McCaddon A, et al. A novel role for vitamin B12: cobalamins are intracellular antioxidants in vitro. Free Radic Biol Med 2009;47:184-8.
27. Fodor E, Barabino S, Montaldo E, et al. Quantitative evaluation of ocular surface inflammation in patients with different grade of conjunctivochalasis. Curr Eye Res 2010;35:665-9.
28. Fenga C, Aragona P, Cacciola A, et al. Ocular discomfort and conjunctival alterations in operating room workers. A single-institution pilot study. Int Arch Occup Environ Health 2001;74:123-8. (Pubitemid 32229215)
29. Fenga C, Aragona P, Cacciola A, et al. Meibomian gland dysfunction and ocular discomfort in video display terminal workers. Eye 2008;22:91-5.
30. Barabino S, Rolando M, Camicione P, et al. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea 2003;22:97-101. (Pubitemid 36701907)
31. Aragona P, Bucolo C, Spinella R, et al. Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients. Invest Ophthalmol Vis Sci 2005;46:4474-9. (Pubitemid 44264541)
32. Aragona P, Di Pietro R, Spinella R, et al. Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome. Br J Ophthalmol 2006;90:166-70. (Pubitemid 43163845)
33. Aragona P, Cannavò SP, Borgia F, et al. Utility of studying the ocular surface in patients with acne vulgaris treated with oral isotretinoin: a randomized controlled trial. Br J Dermatol 2005;152:576-8. (Pubitemid 40547141)
34. Brignole-Baudouin F, Baudouin C, Aragona P, et al. A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol 2011;89:591-7.
35. Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology 1999;106:811-16. (Pubitemid 30194327)
36. Aragona P, Di Stefano G, Ferreri F, et al. Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjögren's syndrome patients. Br J Ophthalmol 2002;86:879-84. (Pubitemid 34827968)
37. Aragona P, Papa V, Micali A, et al. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 2002;86:181-4. (Pubitemid 34127543)
38. Aragona P, Ferreri G, Micali A, et al. Morphological changes of the conjunctival epithelium in contact lens wearers evaluated by impression cytology. Eye 1998;12:461-6. (Pubitemid 28359375)
39. Aragona P, Romeo GF, Puzzolo D, et al. Impression cytology of the conjunctival epithelium in patients with vernal conjunctivitis. Eye 1996;10:82-5. (Pubitemid 26086014)
40. Aragona P, Micali A, Paladino G, et al. Effects of tear substitutes on conjunctival epithelium of mice. Ophthalmic Res 2007;39:265-75. (Pubitemid 47557247)